The Latest Breaking News from Cintas

JPMorgan each month publishes a roster of stocks representing its analysts' top ideas.

Cintas's (NASDAQ:CTAS) short percent of float has risen 7.2% since its last report. The company recently reported that it has 1.17 million shares sold short, which is 1.34% of all regular shares that are available for trading.

Deepening logistical disruptions caused by the Russia-Ukraine war, record-high inflation, and high oil prices have dampened investor sentiment. Furthermore, many economists expect the economy to succumb to a recession, with inflation hitting a fresh 40-year high and oil prices soaring. Therefore, we think it could be wise to bet on…

Upgrades

Cintas Corp's (NASDAQ:CTAS) price target was raised to $493 from $460 by Goldman Sachs analyst George Tong while maintaining the Buy rating on the shares. Tong predicts continued strength from the healthcare sector that is increasingly adopting uniform rental programs at Cintas post-COVID due to cost and hygiene benefits. Related: Cintas' Q3 Results Beat Estimates, Clocks…

Cintas shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Cintas Corp (NASDAQ:CTAS) reported third-quarter revenue growth of 10.3% year-over-year to $1.96 billion and +10% on an organic basis, beating the consensus of $1.91 billion. Adjusted EPS was $2.69 for the quarter, which beat the consensus of $2.43. The operating income increased 24.9% Y/Y to $407.61 million, and the margin expanded by 242…

  Cintas (NASDAQ:CTAS) reported its Q3 earnings results on Wednesday, March 23, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Cintas (NASDAQ:CTAS) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement. Analysts estimate that Cintas will report an earnings per share (EPS) of $2.43.